Prof. Aleksandar Ljubić, MD, Phd, founder of Segova program, talked about polycystic ovaries in an interview in ”Vecernje Novosti” paper. A common hormonal disorder in women of reproductive age, from
Prof. Aleksandar Ljubić, MD, PhD gave an interview to the ”Blic Žena” newspaper on the topic of pandemic and pregnancy, in which he concludes that it is not a time
Prof. Aleksandar Ljubić, MD, PhD, founder of Segova program, was a guest in the show at TV PRVA. He talked about the impact of COVID-19 on pregnancy and fetus and
Trzin, Slovenia (EU), Lutry (Switzerland, CH), 13th March 2020. Medical Biobank Swiss Institute SA (MBSI) and Educell (www.educell.si) are informing that the technology ImmunoARTTM has the potential to significantly reduce
An international group of experts has successfully implemented new therapy in the first seven COVID-19 patients. All patients treated with stem cells survived. This type of therapy has already been
The sample of 93 patients with an average age of 46.64 years has completed two-year monitoring, showing that SEGOVA has a favorable effect on the endocrine status and on the
Although this is a relatively new area of therapy and the results are only now beginning to come in, ovarian rejuvenation is giving a lot of would-be-mothers reason to be
Ovarian Rejuvenation Program – SEGOVA was first introduced in London during our participation at The Fertility Show 2019. Since then, the ovarian rejuvenation procedure has evolved with new components, making
Platelet-rich plasma (PRP) is also known as platelet-rich growth factors (GFs), platelet-rich fibrin (PRF) matrix, PRF, and platelet concentrate. The concept and description of PRP started in the field of
It is well established that full competence of an oocyte (and thus-ovary) requires synchronous nuclear and cytoplasmic maturation. An oocyte contains numerous organelles and molecules that are required for the
Email Us
Quick Links